Silver Book Fact

An opiate agonist often used for persistent pain, tramadol was found in one meta-analysis to significantly reduce neuropathic pain when compared to placebo.

Duehmke R, Derry S, Wiffen P, Bell R, et al. Tramadol for Treating Neuropathic Pain. Cochrane Database of Systematic Reviews. 2017; 6. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003726.pub4/epdf/abstract

Reference

Title
Tramadol for Treating Neuropathic Pain
Publication
Cochrane Database of Systematic Reviews
Publication Date
2017
Authors
Duehmke R, Derry S, Wiffen P, Bell R, et al.
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Pain education programs and pain consultations have been found to improve pain (average pain was 31% versus 20%) and daily interference (20% versus 2.5%) in oncology outpatients. Patient adherence…  
  • 60% of people with persistent back pain who turned to complementary and alternative medicine perceived a “”great deal”” of benefit.  
  • Understanding the role of genetics in pain mechanisms is increasing and the potential now exists to conduct genome-wide screens in model organisms to look for pain-associated genes.  
  • Topical NSAIDs were found in a meta-analysis to be significantly more effective than placebo in reducing persistent pain from musculoskeletal conditions.  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.